Tag: Ixazomib

Added value of ixazomib to lenalidomide plus dexamethasone in transplant-ineligible newly diagnosed MM

Presented By
Prof. Thierry Facon, University Hospital Lille, France
Trial
Phase 3, TOURMALINE-MM2
Conference
ASH 2020
Type
Peer-reviewed article

18 February 2021 10:37
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com